Oncoinvent ASA
Clinical-stage biotech developing radiopharmaceutical therapies for peritoneal cancers.
OCIN | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- NO0010779341 (+1 more)
- LEI:
- 54930076H5GUZRMSNR39
- Country:
- Norway
- Address:
- Gullhaugveien 7, 0484 Oslo
- Website:
- https://www.oncoinvent.com/
- Sector:
- Manufacturing
Description
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies for cancer. The company's core focus is on direct alpha therapy, a technology platform designed to deliver potent, short-range radiation directly to cancerous tumors. Its lead product candidate, Radspherin®, is composed of inorganic microparticles that carry the alpha-emitting radionuclide Radium-224. This formulation is engineered for regional retention and slow degradation, enabling a high radiation dose to be administered within the peritoneal cavity while minimizing systemic exposure. Oncoinvent's clinical programs are primarily investigating the use of Radspherin® for treating metastatic cancers in the peritoneal cavity, including ovarian and colorectal cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-03 08:02 |
Flaggemelding - MP Pensjon PK
|
Norwegian | 731 bytes | ||
| 2025-12-02 15:17 |
Oncoinvent ASA: Notification of trade - primary insider/close associate - Attac…
|
English | 223.9 KB | ||
| 2025-12-02 15:17 |
Oncoinvent ASA: Notification of trade - primary insider/close associate - Attac…
|
English | 67.0 KB | ||
| 2025-12-02 15:17 |
Oncoinvent ASA: Notification of trade - primary insider/close associate
|
English | 3.1 KB | ||
| 2025-12-02 12:21 |
Oncoinvent ASA: Final results of the rights issue
|
English | 12.4 KB | ||
| 2025-12-01 18:45 |
Oncoinvent ASA: Preliminary results of the rights issue
|
English | 10.5 KB | ||
| 2025-12-01 07:00 |
Oncoinvent ASA: Last day of the subscription period in the rights issue
|
English | 10.6 KB | ||
| 2025-11-27 12:59 |
Oncoinvent ASA: Notification of trade - primary insider/close associate - Attac…
|
English | 141.1 KB | ||
| 2025-11-27 12:59 |
Oncoinvent ASA: Notification of trade - primary insider/close associate - Attac…
|
English | 65.7 KB | ||
| 2025-11-27 12:59 |
Oncoinvent ASA: Notification of trade - primary insider/close associate
|
English | 3.4 KB | ||
| 2025-11-25 06:37 |
Oncoinvent ASA: Last day of trading in subscription rights
|
English | 10.6 KB | ||
| 2025-11-17 06:30 |
Oncoinvent ASA: Commencement of the subscription period for the Rights Issue
|
English | 14.7 KB | ||
| 2025-11-14 15:45 |
Oncoinvent ASA: Notice of Extraordinary General Meeting in connection with the …
|
Norwegian | 3.4 MB | ||
| 2025-11-14 15:45 |
Oncoinvent ASA: Notice of Extraordinary General Meeting in connection with the …
|
English | 3.8 KB | ||
| 2025-11-14 14:51 |
Oncoinvent ASA - Receipt of subscription rights in the rights issue by primary …
|
Norwegian | 92.3 KB |
Automate Your Workflow. Get a real-time feed of all Oncoinvent ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oncoinvent ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oncoinvent ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
